Literature DB >> 33633407

Consequences of the COVID-19 pandemic for patients with metabolic diseases.

Stefan R Bornstein1,2,3,4,5, Francesco Rubino6,7, Barbara Ludwig8,9,10,11,12, Hannes Rietzsch8, Peter E H Schwarz8,10,11, Roman N Rodionov8, Kamlesh Khunti13, David Hopkins14, Andreas L Birkenfeld8,6,15,16,17, Bernhard Boehm18,19, Stephanie Amiel6, Richard I G Holt20, Jay S Skyler21, J Hans DeVries22,23, Eric Renard24, Robert H Eckel25, Paul Zimmet26, K G Alberti27, Bruno Geloneze28, Juliana C Chan29, Jean Claude Mbanya30, Henry C Onyegbutulem31, Ambady Ramachandran32, Abdul Basit33, Mohamed Hassanein34, Giatgen A Spinas9, Felix Beuschlein9, Geltrude Mingrone6,35,36.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33633407     DOI: 10.1038/s42255-021-00358-y

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


× No keyword cloud information.
  13 in total

1.  COVID-19: a gray swan's impact on the adoption of novel medical technologies.

Authors:  Denise R Dunlap; Roberto S Santos; Craig M Lilly; Sean Teebagy; Nathaniel S Hafer; Bryan O Buchholz; David D McManus
Journal:  Humanit Soc Sci Commun       Date:  2022-07-08

2.  Functional Capacity in Patients Who Recovered from Mild COVID-19 with Exertional Dyspnea.

Authors:  Yaniv Dotan; Elite Weiner; Merav Zucker-Toledano; Anna Solomonov; Eyal Fuchs; Hanna Dawood; Elad Mor; Moneera Hanna; Rihan Naser-Aldeen; Lea Bentur; Ronen Bar-Yoseph
Journal:  J Pers Med       Date:  2022-05-26

3.  Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel.

Authors:  Wael Al Mahmeed; Khalid Al-Rasadi; Yajnavalka Banerjee; Antonio Ceriello; Francesco Cosentino; Massimo Galia; Su-Yen Goh; Peter Kempler; Nader Lessan; Nikolaos Papanas; Ali A Rizvi; Raul D Santos; Anca P Stoian; Peter P Toth; Manfredi Rizzo
Journal:  Front Cardiovasc Med       Date:  2021-12-15

Review 4.  The impact of the SARS-CoV-2 pandemic on the management of chronic limb-threatening ischemia and wound care.

Authors:  Vickie R Driver; Kara S Couch; Kristen A Eckert; Gary Gibbons; Lorena Henderson; John Lantis; Eric Lullove; Paul Michael; Richard F Neville; Lee C Ruotsi; Robert J Snyder; Fadi Saab; Marissa J Carter
Journal:  Wound Repair Regen       Date:  2021-10-29       Impact factor: 3.401

Review 5.  COVID-19 and metabolic disease: mechanisms and clinical management.

Authors:  Charlotte Steenblock; Peter E H Schwarz; Barbara Ludwig; Andreas Linkermann; Paul Zimmet; Konstantin Kulebyakin; Vsevolod A Tkachuk; Alexander G Markov; Hendrik Lehnert; Martin Hrabě de Angelis; Hannes Rietzsch; Roman N Rodionov; Kamlesh Khunti; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Richard I G Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; K George M M Alberti; Bruno Geloneze; Juliana C Chan; Jean Claude Mbanya; Henry C Onyegbutulem; Ambady Ramachandran; Abdul Basit; Mohamed Hassanein; Gavin Bewick; Giatgen A Spinas; Felix Beuschlein; Rüdiger Landgraf; Francesco Rubino; Geltrude Mingrone; Stefan R Bornstein
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-04       Impact factor: 32.069

6.  In Patients with Obesity, Are Affective Temperaments Associated with Attrition? An Evaluation during and before the SARS-CoV-2 Pandemic.

Authors:  Enrica Marzola; Giovanni Abbate-Daga; Elena Scumaci; Valentina Ponzo; Ilaria Goitre; Marianna Pellegrini; Chiara D'Eusebio; Andrea Benso; Sara Belcastro; Franco De Michieli; Chiara Crespi; Fabio Broglio; Ezio Ghigo; Simona Bo
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

Review 7.  The interface of COVID-19, diabetes, and depression.

Authors:  Charlotte Steenblock; Peter E H Schwarz; Nikolaos Perakakis; Naime Brajshori; Petrit Beqiri; Stefan R Bornstein
Journal:  Discov Ment Health       Date:  2022-03-01

Review 8.  Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.

Authors:  Mohammad Rudiansyah; Saade Abdalkareem Jasim; Zeinab Gol Mohammad Pour; Sara Sohrabi Athar; Ali Salimi Jeda; Rumi Iqbal Doewes; Abduladheem Turki Jalil; D O Bokov; Yasser Fakri Mustafa; Mina Noroozbeygi; Sajad Karampoor; Rasoul Mirzaei
Journal:  J Med Virol       Date:  2022-06-20       Impact factor: 20.693

9.  Incretin-based therapies in 2021 - current status and perspectives for the future.

Authors:  Manfredi Rizzo; Michael A Nauck; Christos S Mantzoros
Journal:  Metabolism       Date:  2021-07-29       Impact factor: 8.694

10.  Molecular Endocrinology and Metabolism in 2021: What's New.

Authors:  Manfredi Rizzo
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.